Protagonist Therapeutics, Inc. Gains 45.89%

Mon, Mar 10, 2025 at 08:11 PM
Protagonist Therapeutics, Inc. Gains 45.89%

Protagonist Therapeutics, Inc. (PTGX:NASDAQ) rocketted at $55.95, a gain of 45.9%. On Mon, Mar 10, 2025, PTGX:NASDAQ hit a New 2-Week High of $55.95. The stock appeared on our News Catalysts scanner on Mon, Mar 10, 2025 at 09:49 AM in the 'BIOTECH' category. From Mon, Feb 24, 2025, the stock recorded 70.00% Up Days and 54.55% Green Days

About Protagonist Therapeutics, Inc. (PTGX:NASDAQ)

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.